Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
September 03 2024 - 5:55AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2024
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
EXHIBIT INDEX
|
Exhibit Number
|
Description
|
|
99.1
|
02
September 2024 - “Total Voting Rights and
Capital”
|
99.1
Haleon plc: Total Voting Rights and Capital
2 September 2024: As
at 31 August 2024 the total number of shares issued by Haleon plc
("Haleon" or the "Company") with rights to vote
is 9,123,638,944 ordinary
shares of £0.01 each. There are no ordinary shares held in
Treasury.
The figure above may
be used by shareholders (and others with notification obligations)
as the denominator for the calculation by which they will determine
if they are required to notify their interest in, or a change to
their interest in, the Company under the
Disclosure and Transparency Rules of the Financial Conduct
Authority.
Notifiable interests in Haleon may be sent to: company.secretary@haleon.com
The person responsible for arranging the release of this
announcement on behalf of Haleon is Amanda Mellor, Company
Secretary.
About Haleon
Haleon (LSE / NYSE: HLN) is a global leader in consumer health,
with a purpose to deliver better everyday health with humanity.
Haleon's product portfolio spans five major categories - Oral
Health, Pain Relief, Respiratory Health, Digestive Health and
Other, and Vitamins, Minerals and Supplements (VMS). Its
long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren,
Theraflu, Otrivin, Polident, parodontax and Centrum - are built on
trusted science, innovation and deep human
understanding.
For more information, please visit www.haleon.com.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
HALEON PLC
(Registrant)
|
|
Date:
September 03, 2024
|
By:
|
/s/
Amanda Mellor
|
|
|
|
Name:
|
Amanda
Mellor
|
|
|
|
Title:
|
Company
Secretary
|
Haleon (NYSE:HLN)
Historical Stock Chart
From Nov 2024 to Dec 2024
Haleon (NYSE:HLN)
Historical Stock Chart
From Dec 2023 to Dec 2024
